Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:INSP NASDAQ:NARI NYSE:NVRO NASDAQ:SWAV NASDAQ:TNDM On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSPInspire Medical Systems$78.03+0.9%$82.84$70.77▼$216.01$2.31B1.16965,240 shs851,424 shsNARIInari Medical$79.97$79.97$39.76▼$79.99$4.68B1.021.49 million shsN/ANVRONevro$5.85+0.1%$5.85$3.17▼$10.34$224.32M0.81818,428 shs753,602 shsSWAVShockwave Medical$334.75$332.85$157.00▼$334.90$12.57B0.88968,088 shsN/ATNDMTandem Diabetes Care$14.79-3.3%$12.62$9.98▼$38.28$999.36M1.481.85 million shs1.26 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSPInspire Medical Systems0.00%+3.72%-2.29%-37.64%-61.33%NARIInari Medical0.00%0.00%0.00%0.00%+80.80%NVRONevro0.00%0.00%0.00%0.00%+8.66%SWAVShockwave Medical0.00%0.00%0.00%0.00%0.00%TNDMTandem Diabetes Care0.00%+5.64%+17.66%+1.09%-58.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINSPInspire Medical Systems$78.03+0.9%$82.84$70.77▼$216.01$2.31B1.16965,240 shs851,424 shsNARIInari Medical$79.97$79.97$39.76▼$79.99$4.68B1.021.49 million shsN/ANVRONevro$5.85+0.1%$5.85$3.17▼$10.34$224.32M0.81818,428 shs753,602 shsSWAVShockwave Medical$334.75$332.85$157.00▼$334.90$12.57B0.88968,088 shsN/ATNDMTandem Diabetes Care$14.79-3.3%$12.62$9.98▼$38.28$999.36M1.481.85 million shs1.26 million shs7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINSPInspire Medical Systems0.00%+3.72%-2.29%-37.64%-61.33%NARIInari Medical0.00%0.00%0.00%0.00%+80.80%NVRONevro0.00%0.00%0.00%0.00%+8.66%SWAVShockwave Medical0.00%0.00%0.00%0.00%0.00%TNDMTandem Diabetes Care0.00%+5.64%+17.66%+1.09%-58.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINSPInspire Medical Systems 2.40Hold$148.0089.67% UpsideNARIInari Medical 2.10Hold$76.33-4.55% DownsideNVRONevro 2.00Hold$5.36-8.29% DownsideSWAVShockwave Medical 0.00N/AN/AN/ATNDMTandem Diabetes Care 2.24Hold$22.1950.02% UpsideCurrent Analyst Ratings BreakdownLatest NVRO, SWAV, TNDM, NARI, and INSP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails10/15/2025TNDMTandem Diabetes CareTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetHold$14.00 ➝ $16.0010/15/2025INSPInspire Medical SystemsTruist FinancialSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetHold$125.00 ➝ $90.0010/10/2025INSPInspire Medical SystemsRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingOutperform$150.0010/8/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)10/8/2025TNDMTandem Diabetes CareWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)10/7/2025TNDMTandem Diabetes CareCitigroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingNeutral$11.00 ➝ $15.0010/7/2025INSPInspire Medical SystemsEvercore ISISubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetOutperform$150.00 ➝ $125.009/29/2025TNDMTandem Diabetes CareCanaccord Genuity GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$24.009/27/2025INSPInspire Medical SystemsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D)9/27/2025TNDMTandem Diabetes CareWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)9/22/2025INSPInspire Medical SystemsUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price TargetBuy ➝ Neutral$230.00 ➝ $89.00(Data available from 10/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINSPInspire Medical Systems$802.80M2.87$1.71 per share45.66$23.01 per share3.39NARIInari Medical$493.63M9.48$0.09 per share906.95$8.07 per share9.91NVRONevro$408.52M0.55N/AN/A$8.10 per share0.72SWAVShockwave Medical$787.97M15.95$4.31 per share77.61$20.02 per share16.72TNDMTandem Diabetes Care$940.20M1.06N/AN/A$4.01 per share3.69Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINSPInspire Medical Systems$53.51M$1.7345.1024.232.436.17%10.38%8.93%11/3/2025 (Estimated)NARIInari Medical-$1.64M-$1.35N/A727.00N/A-13.68%-10.09%-6.60%N/ANVRONevro-$92.21M-$3.05N/AN/AN/A-16.54%-23.52%-10.83%N/ASWAVShockwave Medical$147.28M$4.2878.2154.342.4320.75%24.79%11.95%N/ATNDMTandem Diabetes Care-$96.03M-$3.09N/AN/AN/A-20.51%-65.40%-13.87%11/6/2025 (Estimated)Latest NVRO, SWAV, TNDM, NARI, and INSP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails11/6/2025Q3 2025TNDMTandem Diabetes Care-$0.31N/AN/AN/A$235.80 millionN/A11/3/2025Q3 2025INSPInspire Medical Systems-$0.11N/AN/AN/A$220.39 millionN/A8/6/2025Q2 2025TNDMTandem Diabetes Care-$0.40-$0.48-$0.08-$0.78$238.39 million$240.68 million8/4/2025Q2 2025INSPInspire Medical Systems$0.22$0.45+$0.23-$0.12$214.50 million$217.09 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthINSPInspire Medical SystemsN/AN/AN/AN/AN/ANARIInari MedicalN/AN/AN/AN/AN/ANVRONevroN/AN/AN/AN/AN/ASWAVShockwave MedicalN/AN/AN/AN/AN/ATNDMTandem Diabetes CareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINSPInspire Medical SystemsN/A6.144.84NARIInari MedicalN/A1.771.40NVRONevro0.675.023.76SWAVShockwave Medical0.9713.8112.61TNDMTandem Diabetes Care2.322.441.88Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINSPInspire Medical Systems94.91%NARIInari Medical90.98%NVRONevro95.52%SWAVShockwave Medical95.35%TNDMTandem Diabetes CareN/AInsider OwnershipCompanyInsider OwnershipINSPInspire Medical Systems2.30%NARIInari Medical10.60%NVRONevro3.20%SWAVShockwave Medical3.40%TNDMTandem Diabetes Care1.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINSPInspire Medical Systems1,24629.57 million28.89 millionOptionableNARIInari Medical80058.54 million52.34 millionOptionableNVRONevro1,09038.37 million36.27 millionOptionableSWAVShockwave Medical1,46837.54 million36.27 millionOptionableTNDMTandem Diabetes Care2,65067.57 million66.29 millionOptionableNVRO, SWAV, TNDM, NARI, and INSP HeadlinesRecent News About These CompaniesTandem Diabetes Care (TNDM) Is Up 5.6% After Pump Correction Spurs Legal Scrutiny and Insider Buying – Has the Bull Case Changed?October 18 at 10:53 AM | finance.yahoo.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDMOctober 18 at 10:00 AM | prnewswire.comTandem Diabetes Care (NASDAQ:TNDM) Rating Increased to Hold at Wall Street ZenOctober 18 at 2:50 AM | marketbeat.comTNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 17 at 5:00 PM | globenewswire.comTandem Diabetes Care (NASDAQ:TNDM) Shares Acquired Rep. Josh GottheimerOctober 17 at 5:05 AM | marketbeat.comBayforest Capital Ltd Has $173,000 Stock Position in Tandem Diabetes Care, Inc. $TNDMOctober 17 at 4:46 AM | marketbeat.comRosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation – TNDMOctober 16, 2025 | businesswire.comBreaking Down Tandem Diabetes Care: 13 Analysts Share Their ViewsOctober 16, 2025 | benzinga.comTandem Diabetes Care Stock (TNDM) Opinions on FDA Clearance and Legal ConcernsOctober 16, 2025 | quiverquant.comQTNDM Investors Have Opportunity to Join Tandem Diabetes Care, Inc. Fraud Investigation with the Schall Law FirmOctober 16, 2025 | prnewswire.comRosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMOctober 15, 2025 | prnewswire.comTNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 13, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDMOctober 13, 2025 | prnewswire.comOngoing Securities Investigation into Tandem Diabetes Care, Inc. (TNDM) - Contact Levi & KorsinskyOctober 13, 2025 | theglobeandmail.comCiti Remains a Hold on Tandem Diabetes Care (TNDM)October 13, 2025 | theglobeandmail.comRosen Law Firm Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDMOctober 10, 2025 | prnewswire.comOngoing Investigation: Tandem Diabetes Care, Inc. (TNDM) May Have Misled Shareholders - Levi & Korsinsky InvestigatesOctober 10, 2025 | theglobeandmail.comTandem Diabetes Care's (TNDM) "Sell (E+)" Rating Reiterated at Weiss RatingsOctober 9, 2025 | marketbeat.comTNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your RightsOctober 9, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDMOctober 8, 2025 | prnewswire.comCitigroup Maintains Tandem Diabetes Care (TNDM) Neutral RecommendationOctober 8, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNVRO, SWAV, TNDM, NARI, and INSP Company DescriptionsInspire Medical Systems NYSE:INSP$78.03 +0.69 (+0.89%) Closing price 10/17/2025 03:59 PM EasternExtended Trading$78.00 -0.03 (-0.04%) As of 10/17/2025 05:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.Inari Medical NASDAQ:NARIInari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.Nevro NYSE:NVRONevro Corp., a medical device company, engages in the provision of products for patients suffering from chronic pain in the United States and internationally. The company provides HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS implantable pulse generator (IPG) system, an evidence-based neuromodulation system for the treatment of chronic back and leg pain through paresthesia-free 10 kHz therapy, as well as offers Senza II and Senza Omnia SCS IPG systems. It also offers Senza HFX iQ platform, that includes HFX iQ implantable pulse generator, HFX trial stimulator, and HFX iQ patient remote, as well as HFX App, a patient remote control and the wireless trialing system; and provides sacroiliac joint fusion devices under NevroV1, NevroFix, and NevroPro brands. In addition, the company offers surpass surgical and percutaneous leads. It sells its products through its direct sales force, and a network of sales agents and independent distributors. The company was incorporated in 2006 and is headquartered in Redwood City, California.Shockwave Medical NASDAQ:SWAVShockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.Tandem Diabetes Care NASDAQ:TNDM$14.79 -0.50 (-3.27%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$14.96 +0.17 (+1.15%) As of 10/17/2025 05:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Broadcom Inks OpenAI Deal: Why It's A Huge Win for AVGO Stock Institutions Are Fueling CrowdStrike’s Next Leg Higher This AI Chip Giant Could Be the Market’s Next Big Winner JPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall? Microsoft & NVIDIA Unveil GB300 Supercomputer as AI Race Heats Up This Less-Hyped Tech Stock Could Be the Key to the Next AI Wave Archer Buys Rival's Patent Treasure Trove in Strategic Move Prologis Stock Surges: Why the Rally May Continue Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
